Ozempic and its analogues continued to conquer the world in 2024. These are no longer just medicines for people with diabetes and obesity, but real miracle pills
They can even help in the fight against cancer and alcohol addiction Jaap Arriens/NurPhoto/Getty Images At the end of 2023, Science magazine named semaglutide, better known under the trade name Ozempic, the scientific breakthrough of the year. The drug managed to show previously unprecedented results in the treatment of obesity, and the capitalization of the company producing it, Novo Nordisk, at one point exceeded the GDP of its native Denmark.